Skip to content
healthcare.dev

Cherry Antacid

NDC 84269-2517, Calcium Carbonate, tablet, from Wildman Business Group.

Product NDC
84269-2517
Status
Listed
Labeler
Wildman Business Group
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M001
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/84269-2517 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CALCIUM CARBONATE500 mg/1

Pharmacologic classes

Blood Coagulation Factor [EPC]; Calcium [CS]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]

Package NDCNDC-11Package
84269-2517-18426925170150 PACKET in 1 BOX (84269-2517-1) / 2 TABLET in 1 PACKET
84269-2517-284269251702125 PACKET in 1 BOX (84269-2517-2) / 2 TABLET in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 84269-2517 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/84269-2517 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 84269-2517. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.